Skip to contentNorwalk Leslie V — NEUROCRINE BIOSCIENCES INC insider: 133 transactions · InsiderLensNorwalk Leslie V
- Director at GLOBUS MEDICAL INC · on record since Sep 6, 2023
- Director at Volcano CORP · on record since Oct 26, 2011
- Director at NEUROCRINE BIOSCIENCES INC · on record since May 14, 2026
- Director at CVS CORP · on record since May 15, 2026
- Director at NUVASIVE INC · on record since May 23, 2014
- Director at Press Ganey Holdings, Inc. · on record since May 22, 2015
- Director at ENDOLOGIX INC /DE/ · on record since May 4, 2015
- Director at PROVIDENCE SERVICE CORP · on record since Nov 5, 2015
- Director at MAGELLAN HEALTH SERVICES INC · on record since Jun 24, 2019
- Director at ARVINAS, INC. · on record since Jul 26, 2019
- Director at CENTENE CORP · on record since Jan 18, 2022
Insider trading activity of Norwalk Leslie V
- Transactions on record
- 133
- since Oct 26, 2011
- Open-market buys
- 0
- Open-market sells
- 10
- $4.2M
- Companies traded
- 11
- last filing Jun 26, 2026
Figures computed from official regulatory filings — methodology.
Companies where Norwalk Leslie V has traded
- ARVINAS, INC.12 tx · Jun 26, 2026
- NEUROCRINE BIOSCIENCES INC30 tx · $5.3M · Jun 8, 2026
- CVS CORP4 tx · $517.4K · May 15, 2026
- GLOBUS MEDICAL INC10 tx · $1.2M · Jan 23, 2026
- PROVIDENCE SERVICE CORP10 tx · Feb 16, 2024
- NUVASIVE INC26 tx · Sep 5, 2023
- CENTENE CORP3 tx · $31.3K · Apr 4, 2022
- MAGELLAN HEALTH SERVICES INC5 tx · Jan 4, 2022
- ENDOLOGIX INC /DE/6 tx · $60.2K · Aug 6, 2019
- Press Ganey Holdings, Inc.
Track record of Norwalk Leslie V
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Norwalk Leslie V
Co-insiders of Norwalk Leslie V
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
3 tx · $1.2M · Oct 25, 2016
DP IV ASSOCIATES LPNUVASIVE INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 26, 2026 | AwardD | 22,714 | 0.00 USD | — | SEC |
| Jun 26, 2026 | Award | 15,527 | 0.00 USD | — | SEC |
| Jun 8, 2026 | Sell | -1,250 | 168.06 USD | $210.1K | SEC |
| May 29, 2026 | AwardD | 2,624 | 0.00 USD | $0 | SEC |
| May 29, 2026 | AwardD | 1,284 | 0.00 USD | $0 | SEC |
| May 21, 2026 | ExerciseD | -1,659 | 0.00 USD | $0 | SEC |
| May 21, 2026 | Exercise | 1,659 | 0.00 USD | $0 | SEC |
| May 15, 2026 | Award | 1,447 | 97.15 USD | $140.6K | SEC |
| May 14, 2026 | Sell | -3,810 | 155.01 USD | $590.6K | SEC |
| Jan 23, 2026 | AwardD | 15,000 | 0.00 USD | $0 | SEC |
| Jan 12, 2026 | Sell | -2,000 | 101.10 USD | $202.2K | SEC |
| Dec 17, 2025 | ExerciseD | -1,724 | 0.00 USD | $0 | SEC |
| Dec 17, 2025 | Sell | -1,190 | 155.09 USD | $184.6K | SEC |
| Dec 17, 2025 | ExerciseD | -8,276 | 0.00 USD | $0 | SEC |
| Dec 17, 2025 | Exercise | 1,724 | 84.95 USD | $146.5K | SEC |
| Dec 17, 2025 | Exercise | 8,276 | 92.35 USD | $764.3K | SEC |
| Dec 17, 2025 | Sell | -5,000 | 152.23 USD | $761.2K | SEC |
| Dec 16, 2025 | Sell | -4,000 | 88.85 USD | $355.4K | SEC |
| Nov 21, 2025 | Award | 1,652 | 76.04 USD | $125.6K | SEC |
| Jun 27, 2025 | AwardD | 23,105 | 0.00 USD | $0 | SEC |
| Jun 27, 2025 | Award | 16,025 | 0.00 USD | $0 | SEC |
| May 22, 2025 | AwardD | 3,305 | 0.00 USD | $0 | SEC |
| May 22, 2025 | AwardD | 1,659 | 0.00 USD | $0 | SEC |
| May 22, 2025 | Exercise | 1,435 | 0.00 USD | $0 | SEC |
| May 22, 2025 | ExerciseD | -1,435 | 0.00 USD | $0 | SEC |